$LH — BUY 📊

$LH — BUY 📊 Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. 🎯 Q1 FY26 | Rev $4B | EPS $4.25 vs $4.12 🟢 💡 Consensus EPS of $4.12 was beaten by 3.4%, but the guidance raise implies FY2026 EPS of ~$18, which is well above current sell-side estimates. The market is underestimating the sustainability of margin expansion and volume growth, creating a variant view of 15-20% upside to forward estimates. 📉 Reward/Risk: 3.8:1 🏢 Business Quality: 7/10 - Dominant scale in lab services and a top-tier CRO, with wide moat from network density and longitudinal data, though exposed to regulatory and reimbursement risks. 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/LH0617 Also in play: $LUV $DAL $UAL $AAL $JBLU $BA

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.